研究员：孙海洋 公司发布2025 半年度业绩预告 机构：天风证券 通过日本本土化生产，可有效对冲中美贸易摩擦导致的关税成本上升风险，确保对美国市场的稳定供 应。日本产线的区位优势亦将提升亚太地区客户响应速度。结合公司现有产能布局，我们预计日本车房 产线将会同位于中国江苏和上海的两大生产基地发挥协同效应，降低综合生产成本。多元化生产基地布 局将有望增强应对地缘政治不确定性及汇率波动的能力。 XR 业务积极接洽客户，研发中心助力创新升级XR 业务方面（包括AR 和AI 眼镜等），在与美国多家 头部企业在内的多个全球领先的科技和消费电子企业持续合作的同时，公司也积极拓展与其他国内外科 技和消费电子企业客户的业务合作机会。公司将继续配合客户持续推进现有研发项目，并积极开拓新项 目，为未来可能的AR 或AI 眼镜等项目的批量生产做准备。 公司在积极布局国家级研发中心的规划，包括新建XR（扩展现实）研发中心在内，公司将持续投入， 强化项目和知识产权管理机制，注重研发成果转化和产业协同效应。除此以外，公司也在不断研发不同 折射率、不同功能叠加创新产品，积极改进和升级现有产品。 调整盈利预测，维持"买入"评级 公司作为树脂镜 ...

Group 1 - The report highlights high-growth potential sectors for Q2 2025, including optical modules, diesel generators, innovative pharmaceuticals, and deep-sea technology, driven by increasing demand and supportive policies [2][22][23] - Key themes identified include anti-involution for high-quality industry development, deep-sea technology as a pillar of marine economic strategy, and the acceleration of global stablecoin regulatory frameworks [2][23] - The report notes that the central bank is enhancing financial support for the real economy and expanding the technical standard system for emerging industries [2][23] Group 2 - The report on interest rates indicates that the net issuance of government bonds will remain relatively high in the second half of the year, with a more uniform monthly issuance pattern expected [3][28] - It is anticipated that the central bank will continue to use various tools to stabilize the funding environment, with potential for a reserve requirement ratio cut in the third quarter [3][30] - The bond market is experiencing a shift from a bear to a bull market, with a notable correlation between stock and bond performance observed in the second quarter [5][31] Group 3 - The report on Chip Dynamics (688582) indicates that the company is a leader in MEMS sensors, with projected revenues of 4.05 billion yuan and a net profit of 2.22 billion yuan for 2024, maintaining a gross margin above 70% [9][35] - The company has achieved a 23.45% market share in MEMS gyroscopes, reflecting a 14 percentage point increase since 2019, and is positioned to benefit from the growth in smart driving and industrial automation [9][35][36] - The IMU segment is expected to grow rapidly, with a CAGR of 175.8% from 2021 to 2024, driven by demand in low-altitude economy, smart driving, and humanoid robots [9][36][37] Group 4 - The report on Kangnait Optical (02276) forecasts a net profit increase of no less than 30% for the first half of 2025, driven by global strategic expansion and product structure optimization [11] - The company is enhancing its supply chain resilience by establishing a new high-end lens production line in Japan, which will mitigate tariff risks and ensure stable supply to the U.S. market [11] - The report anticipates continued growth in the resin lens market, with a focus on functional and customized lenses, leading to improved profitability [11] Group 5 - The report on Jinhui Industrial (002597) highlights the approval of D-alloheptulose as a food ingredient, marking a significant step in aligning domestic applications with international standards [12][16] - The company is positioned as the second approved enzyme manufacturer for D-alloheptulose in China, showcasing its technological leadership in functional sweeteners [12][16] - The projected net profits for Jinhui Industrial are 1.171 billion yuan, 2.118 billion yuan, and 2.365 billion yuan for 2025-2027, maintaining a "buy" rating [12][16]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [4]. Core Viewpoints - The company expects a year-on-year increase of no less than 30% in net profit attributable to shareholders for the first half of 2025, driven by strong sales growth of high refractive index and functional products, leading to an increase in average selling prices [1]. - The company is one of the few manufacturers capable of producing resin lenses with a refractive index of 1.74, and its C2M model effectively ensures the delivery efficiency of customized glasses [1]. - The company plans to invest approximately $4 million to build an automated resin lens production line in Japan, aimed at enhancing its production capacity for high-end customized lenses and improving supply chain resilience [2]. - The new production line is expected to increase annual production capacity by 20% compared to existing facilities and will help mitigate risks associated with trade tensions between China and the U.S. [2]. - The company is actively engaging with leading global technology and consumer electronics firms in its XR (Extended Reality) business, preparing for potential mass production of AR and AI glasses [3]. - The establishment of a national-level R&D center will further strengthen the company's innovation capabilities and project management [3]. Summary by Sections Financial Performance - The company forecasts a net profit of no less than 271 million yuan for the first half of 2025, reflecting a robust growth trajectory [1]. - Revised profit forecasts for 2025-2027 are 560 million, 670 million, and 790 million yuan, respectively, with corresponding P/E ratios of 31X, 26X, and 22X [4]. Production and Supply Chain - The new Japanese production line is expected to enhance the company's ability to respond to customer needs in the Asia-Pacific region and improve overall production cost efficiency [2]. - The diversified production base is anticipated to strengthen the company's resilience against geopolitical uncertainties and currency fluctuations [2]. Research and Development - The company is committed to continuous investment in R&D, focusing on innovative products with varying refractive indices and functionalities [3]. - The establishment of an XR R&D center is part of the company's strategy to enhance its technological capabilities and foster collaboration with industry leaders [3].

6月16日，国内光学镜片龙头企业明月镜片发布行业首创的明月镜片眼健康产业园方案，官方介 绍，该产业园将采用国际先进的生产技术和管理模式，打造集研发、生产、游学、体验为一体的现代化 产业园区。 作为A股唯一一家以光学树脂镜片为主业的上市公司，明月镜片的业务涵盖镜片、镜片原料、成 镜、镜架等产品的研发、设计、生产和销售。公司核心产品为中高档光学树脂镜片，镜片产品以自有知 名品牌"明月"为主。2021年公司在A股上市，同年推出"轻松控""轻松控Pro"青少年近视管理镜片。 "过去五年，我们在研发上累计投入约1.5亿元，未来五年，我们预计研发投入不低于3亿元且不低 于销售收入的5%，这是最低数，如有需要，不设上限"。明月镜片董事长谢公晚在6月16日公开表示。 据上海市领军人才、上海理工大学特聘教授常琛亮介绍，AI能显著赋能光学技术。同日，常琛亮 围绕基于AI全息的三维VR/AR显示、AI赋能的新型计算机成像技术、AI光学前景三个方面阐述 了"AI+光学研究"。 常琛亮指出，传统光学成像存在像素模糊、色差和畸变等问题，而计算光学成像平台将是解决传统 光学问题的最优方案。他进一步表示，计算光学是指在传统光学基础上，叠加了 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6][86]. Core Views - The company is a leading resin lens manufacturer with a strong focus on R&D and a robust supply chain, which enhances its competitive edge. The partnership with GoerTek in the XR field is expected to drive growth and open new market opportunities [5][15][75]. Summary by Sections Company Overview - The company specializes in the R&D, production, and sales of resin lenses, with plans to establish overseas production bases starting in 2024. It has a concentrated shareholding structure and announced an equity incentive plan in November 2024, with profit growth targets for 2025-2027 set at no less than 21%/17%/15% [3][20]. Financial Performance - In 2024, the company achieved revenue of 2.061 billion yuan, a year-on-year increase of 17.1%, and a net profit of 428 million yuan, up 31% year-on-year. The revenue growth from 2018 to 2024 has a CAGR of 15.8%, while net profit has a CAGR of 32.7% [3][24][25]. Business Structure and Supply Chain - The company has built a strong supply chain through high R&D investment and stable raw material sourcing, maintaining over 30% procurement from Mitsui Chemicals. The business structure has been optimized, with a growing proportion of customized lenses, which accounted for 19.2% of revenue in 2024, up 2.8 percentage points from 2018 [4][49][63]. XR Business Development - The establishment of an XR R&D center and collaboration with GoerTek are expected to enhance the company's capabilities in the XR market. The company has signed supply framework agreements with multinational consumer electronics firms, indicating a positive outlook for XR product growth [5][75][76]. Earnings Forecast and Investment Advice - The company is projected to achieve revenue growth rates of 15%/14%/12% and net profit growth rates of 23%/19%/15% from 2025 to 2027. The report suggests that the company's strong ODM operations and increasing share of customized and functional lenses will support a rise in profitability [6][78][86].